JP2012517971A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012517971A5 JP2012517971A5 JP2011549537A JP2011549537A JP2012517971A5 JP 2012517971 A5 JP2012517971 A5 JP 2012517971A5 JP 2011549537 A JP2011549537 A JP 2011549537A JP 2011549537 A JP2011549537 A JP 2011549537A JP 2012517971 A5 JP2012517971 A5 JP 2012517971A5
- Authority
- JP
- Japan
- Prior art keywords
- triazolo
- chloro
- pyridin
- phenyl
- phenylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940002612 prodrug Drugs 0.000 claims 24
- 239000000651 prodrug Substances 0.000 claims 24
- 150000003839 salts Chemical class 0.000 claims 10
- 239000012453 solvate Substances 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 9
- -1 C 1 -C 4 alkyl Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 3
- BARSDANYGJRCIS-UHFFFAOYSA-N 1-[4-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-3-(2-pyrrolidin-1-ylethyl)imidazolidin-2-one Chemical compound OC1=CC=C(Cl)C(C2=CN3N=C(NC=4C=CC(=CC=4)N4C(N(CCN5CCCC5)CC4)=O)N=C3C=C2)=C1 BARSDANYGJRCIS-UHFFFAOYSA-N 0.000 claims 2
- DSPDRCOCBFODME-FSRHSHDFSA-N 2-[4-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenoxy]-1-[(3r)-3-(dimethylamino)pyrrolidin-1-yl]ethanone;hydrochloride Chemical compound Cl.C1[C@H](N(C)C)CCN1C(=O)COC(C=C1)=CC=C1NC1=NN2C=C(C=3C(=CC=C(O)C=3)Cl)C=CC2=N1 DSPDRCOCBFODME-FSRHSHDFSA-N 0.000 claims 2
- YFJQQRXVDMDLDE-UHFFFAOYSA-N 4-chloro-3-[2-[3-(2-pyrrolidin-1-ylethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound OC1=CC=C(Cl)C(C2=CN3N=C(NC=4C=C(OCCN5CCCC5)C=CC=4)N=C3C=C2)=C1 YFJQQRXVDMDLDE-UHFFFAOYSA-N 0.000 claims 2
- CLBQOSXQVQDPBN-UHFFFAOYSA-N 4-chloro-3-[2-[4-(2-pyrrolidin-1-ylethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyridin-7-yl]phenol;hydrochloride Chemical compound Cl.OC1=CC=C(Cl)C(C2=CC3=NC(NC=4C=CC(OCCN5CCCC5)=CC=4)=NN3C=C2)=C1 CLBQOSXQVQDPBN-UHFFFAOYSA-N 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- ROAWFGXZLSXEMC-NRFANRHFSA-N (2s)-1-[2-[4-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenoxy]acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)COC(C=C1)=CC=C1NC1=NN2C=C(C=3C(=CC=C(O)C=3)Cl)C=CC2=N1 ROAWFGXZLSXEMC-NRFANRHFSA-N 0.000 claims 1
- ZBDPZYTWLRKACH-UHFFFAOYSA-N 1-[4-[4-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]piperazin-1-yl]-2-methoxyethanone Chemical compound C1CN(C(=O)COC)CCN1C(C=C1)=CC=C1NC1=NN2C=C(C=3C(=CC=C(O)C=3)Cl)C=CC2=N1 ZBDPZYTWLRKACH-UHFFFAOYSA-N 0.000 claims 1
- PLJUZHRXSVGDPZ-UHFFFAOYSA-N 1-[4-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-3-(2-methoxyethyl)imidazolidin-2-one Chemical compound O=C1N(CCOC)CCN1C(C=C1)=CC=C1NC1=NN2C=C(C=3C(=CC=C(O)C=3)Cl)C=CC2=N1 PLJUZHRXSVGDPZ-UHFFFAOYSA-N 0.000 claims 1
- WJEJGIVUBFILHU-UHFFFAOYSA-N 1-[4-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]-3-(2-pyrrolidin-1-ylethyl)urea Chemical compound OC1=CC=C(Cl)C(C2=CN3N=C(NC=4C=CC(NC(=O)NCCN5CCCC5)=CC=4)N=C3C=C2)=C1 WJEJGIVUBFILHU-UHFFFAOYSA-N 0.000 claims 1
- YCRZYLWMKQNAPY-UHFFFAOYSA-N 1-[4-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]imidazolidin-2-one Chemical compound OC1=CC=C(Cl)C(C2=CN3N=C(NC=4C=CC(=CC=4)N4C(NCC4)=O)N=C3C=C2)=C1 YCRZYLWMKQNAPY-UHFFFAOYSA-N 0.000 claims 1
- ZWTWEMOWSXHKJW-UHFFFAOYSA-N 2-[3-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenoxy]acetamide Chemical compound NC(=O)COC1=CC=CC(NC2=NN3C=C(C=CC3=N2)C=2C(=CC=C(O)C=2)Cl)=C1 ZWTWEMOWSXHKJW-UHFFFAOYSA-N 0.000 claims 1
- LSEVTGUOCNKMKV-UHFFFAOYSA-N 2-[4-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenoxy]acetamide Chemical compound C1=CC(OCC(=O)N)=CC=C1NC1=NN2C=C(C=3C(=CC=C(O)C=3)Cl)C=CC2=N1 LSEVTGUOCNKMKV-UHFFFAOYSA-N 0.000 claims 1
- GMVUWYZCXDMBMZ-UHFFFAOYSA-N 3-(2-anilino-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-chlorophenol Chemical compound ClC1=C(C=C(C=C1)O)C=1C=CC=2N(C=1)N=C(N=2)NC1=CC=CC=C1 GMVUWYZCXDMBMZ-UHFFFAOYSA-N 0.000 claims 1
- PRAPBCUUVYLTGL-UHFFFAOYSA-N 3-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC(NC2=NN3C=C(C=CC3=N2)C=2C(=CC=C(O)C=2)Cl)=C1 PRAPBCUUVYLTGL-UHFFFAOYSA-N 0.000 claims 1
- COTGLRCWUCISBD-UHFFFAOYSA-N 4-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]benzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N)=CC=C1NC1=NN2C=C(C=3C(=CC=C(O)C=3)Cl)C=CC2=N1 COTGLRCWUCISBD-UHFFFAOYSA-N 0.000 claims 1
- OKTFILYBMNEOHV-UHFFFAOYSA-N 4-chloro-3-[2-(3-pyrazol-1-ylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound OC1=CC=C(Cl)C(C2=CN3N=C(NC=4C=C(C=CC=4)N4N=CC=C4)N=C3C=C2)=C1 OKTFILYBMNEOHV-UHFFFAOYSA-N 0.000 claims 1
- WBAKOYJZUHSKFQ-UHFFFAOYSA-N 4-chloro-3-[2-(4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NN2C=C(C=3C(=CC=C(O)C=3)Cl)C=CC2=N1 WBAKOYJZUHSKFQ-UHFFFAOYSA-N 0.000 claims 1
- NFXXTJJXFUIOOE-UHFFFAOYSA-N 4-chloro-3-[2-(4-phenoxyanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound OC1=CC=C(Cl)C(C2=CN3N=C(NC=4C=CC(OC=5C=CC=CC=5)=CC=4)N=C3C=C2)=C1 NFXXTJJXFUIOOE-UHFFFAOYSA-N 0.000 claims 1
- VLZZRUWVKKOLCI-UHFFFAOYSA-N 4-chloro-3-[2-(4-phenylmethoxyanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound OC1=CC=C(Cl)C(C2=CN3N=C(NC=4C=CC(OCC=5C=CC=CC=5)=CC=4)N=C3C=C2)=C1 VLZZRUWVKKOLCI-UHFFFAOYSA-N 0.000 claims 1
- WLYVHEKYWMDHQR-UHFFFAOYSA-N 4-chloro-3-[2-[3-(2-morpholin-4-ylethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound OC1=CC=C(Cl)C(C2=CN3N=C(NC=4C=C(OCCN5CCOCC5)C=CC=4)N=C3C=C2)=C1 WLYVHEKYWMDHQR-UHFFFAOYSA-N 0.000 claims 1
- FWHMELQUPGZDDN-UHFFFAOYSA-N 4-chloro-3-[2-[3-(hydroxymethyl)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound OCC1=CC=CC(NC2=NN3C=C(C=CC3=N2)C=2C(=CC=C(O)C=2)Cl)=C1 FWHMELQUPGZDDN-UHFFFAOYSA-N 0.000 claims 1
- XIFDOGHMRPWKLS-UHFFFAOYSA-N 4-chloro-3-[2-[3-[2-(dimethylamino)ethoxy]anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound CN(C)CCOC1=CC=CC(NC2=NN3C=C(C=CC3=N2)C=2C(=CC=C(O)C=2)Cl)=C1 XIFDOGHMRPWKLS-UHFFFAOYSA-N 0.000 claims 1
- JFNQPGBIFIFRIS-UHFFFAOYSA-N 4-chloro-3-[2-[4-(2-hydroxyethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound C1=CC(OCCO)=CC=C1NC1=NN2C=C(C=3C(=CC=C(O)C=3)Cl)C=CC2=N1 JFNQPGBIFIFRIS-UHFFFAOYSA-N 0.000 claims 1
- PKDLWUMEXRMGQO-UHFFFAOYSA-N 4-chloro-3-[2-[4-(2-morpholin-4-ylethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound OC1=CC=C(Cl)C(C2=CN3N=C(NC=4C=CC(OCCN5CCOCC5)=CC=4)N=C3C=C2)=C1 PKDLWUMEXRMGQO-UHFFFAOYSA-N 0.000 claims 1
- LZWAVRVFEJGPHF-UHFFFAOYSA-N 4-chloro-3-[2-[4-(2-piperazin-1-ylethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound OC1=CC=C(Cl)C(C2=CN3N=C(NC=4C=CC(OCCN5CCNCC5)=CC=4)N=C3C=C2)=C1 LZWAVRVFEJGPHF-UHFFFAOYSA-N 0.000 claims 1
- YYISBQNDIGHJEW-UHFFFAOYSA-N 4-chloro-3-[2-[4-(hydroxymethyl)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound C1=CC(CO)=CC=C1NC1=NN2C=C(C=3C(=CC=C(O)C=3)Cl)C=CC2=N1 YYISBQNDIGHJEW-UHFFFAOYSA-N 0.000 claims 1
- FVMLVNPROHOXBY-UHFFFAOYSA-N 4-chloro-3-[2-[4-(trifluoromethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound OC1=CC=C(Cl)C(C2=CN3N=C(NC=4C=CC(OC(F)(F)F)=CC=4)N=C3C=C2)=C1 FVMLVNPROHOXBY-UHFFFAOYSA-N 0.000 claims 1
- HPCXHFPKJGZKKT-UHFFFAOYSA-N 4-chloro-3-[2-[4-[2-(dimethylamino)ethoxy]anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenol Chemical compound C1=CC(OCCN(C)C)=CC=C1NC1=NN2C=C(C=3C(=CC=C(O)C=3)Cl)C=CC2=N1 HPCXHFPKJGZKKT-UHFFFAOYSA-N 0.000 claims 1
- QSWJEWQNQNGKKP-UHFFFAOYSA-N 5-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=CC=1NC(=NN1C=2)N=C1C=CC=2C1=CC(O)=CC=C1Cl QSWJEWQNQNGKKP-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 101100295741 Gallus gallus COR4 gene Proteins 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- CXQZKNRYQQRGQG-UHFFFAOYSA-N [4-[4-[[6-(2-chloro-5-hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]phenyl]piperazin-1-yl]-pyridin-4-ylmethanone Chemical compound OC1=CC=C(Cl)C(C2=CN3N=C(NC=4C=CC(=CC=4)N4CCN(CC4)C(=O)C=4C=CN=CC=4)N=C3C=C2)=C1 CXQZKNRYQQRGQG-UHFFFAOYSA-N 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 150000001733 carboxylic acid esters Chemical class 0.000 claims 1
- 230000007073 chemical hydrolysis Effects 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 230000007071 enzymatic hydrolysis Effects 0.000 claims 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 150000003014 phosphoric acid esters Chemical class 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09360013.8 | 2009-02-13 | ||
| EP09360013 | 2009-02-13 | ||
| PCT/EP2010/051556 WO2010092041A1 (en) | 2009-02-13 | 2010-02-09 | [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012517971A JP2012517971A (ja) | 2012-08-09 |
| JP2012517971A5 true JP2012517971A5 (cg-RX-API-DMAC7.html) | 2013-05-02 |
Family
ID=42229029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011549537A Pending JP2012517971A (ja) | 2009-02-13 | 2010-02-09 | キナーゼ阻害薬としての［１，２，４］トリアゾロ［１，５−ａ］ピリジン類 |
Country Status (24)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2438066A2 (en) | 2009-06-05 | 2012-04-11 | Cephalon, Inc. | PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a]PYRIDINE DERIVATIVES |
| EP2343295A1 (en) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridine derivates |
| EP2343297A1 (en) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridines |
| EP2343294A1 (en) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Substituted triazolopyridines |
| UY33452A (es) | 2010-06-16 | 2012-01-31 | Bayer Schering Pharma Ag | Triazolopiridinas sustituidas |
| AR081960A1 (es) * | 2010-06-22 | 2012-10-31 | Fovea Pharmaceuticals Sa | Compuestos heterociclicos, su preparacion y su aplicacion terapeutica |
| RS54044B1 (sr) | 2011-04-21 | 2015-10-30 | Bayer Intellectual Property Gmbh | Triazolopiridini |
| WO2012160029A1 (en) | 2011-05-23 | 2012-11-29 | Bayer Intellectual Property Gmbh | Substituted triazolopyridines |
| UA112096C2 (uk) | 2011-12-12 | 2016-07-25 | Байєр Інтеллектуал Проперті Гмбх | Заміщені триазолопіридини та їх застосування як інгібіторів ttk |
| KR20130091464A (ko) | 2012-02-08 | 2013-08-19 | 한미약품 주식회사 | 타이로신 카이네이즈 억제 활성을 갖는 트리아졸로피리딘 유도체 |
| WO2013135612A1 (en) | 2012-03-14 | 2013-09-19 | Bayer Intellectual Property Gmbh | Substituted imidazopyridazines |
| SG11201408419QA (en) | 2012-07-10 | 2015-01-29 | Bayer Pharma AG | Method for preparing substituted triazolopyridines |
| WO2014020043A1 (en) | 2012-08-02 | 2014-02-06 | Bayer Pharma Aktiengesellschaft | Combinations for the treatment of cancer |
| AP2015008898A0 (en) | 2013-06-11 | 2015-12-31 | Bayer Pharma AG | Prodrug derivatives of substituted triazolopyridines |
| US20230055321A1 (en) * | 2019-11-22 | 2023-02-23 | Medshine Discovery Inc. | Pyrimidopyrrole spiro compounds and derivatives thereof as dna-pk inhibitors |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6056684B2 (ja) | 1977-11-07 | 1985-12-11 | 東興薬品工業株式会社 | 点眼剤 |
| US4271143A (en) | 1978-01-25 | 1981-06-02 | Alcon Laboratories, Inc. | Sustained release ophthalmic drug dosage |
| US4407792A (en) | 1979-05-09 | 1983-10-04 | Alcon Laboratories, Inc. | Sustained release ophthalmic drug dosage |
| EP0163696B1 (en) | 1983-11-14 | 1992-11-25 | Columbia Laboratories, Inc. | Use of a bioadhesive |
| US5041434A (en) | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
| EP1235815A1 (en) | 1999-11-22 | 2002-09-04 | Warner-Lambert Company | Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| WO2004058769A2 (en) * | 2002-12-18 | 2004-07-15 | Vertex Pharmaceuticals Incorporated | Triazolopyridazines as protein kinases inhibitors |
| MXPA05007503A (es) | 2003-01-17 | 2005-09-21 | Warner Lambert Co | Heterociclicos 2-aminopiridina sustituidos como inhibidores de proliferacion celular. |
| CN1897950A (zh) * | 2003-10-14 | 2007-01-17 | 惠氏公司 | 稠合芳基和杂芳基衍生物及其使用方法 |
| US7691866B2 (en) | 2003-10-16 | 2010-04-06 | Novartis Vaccines And Diagnostics, Inc. | 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines and methods of their use as inhibitors of Raf kinase |
| EP2543376A1 (en) | 2004-04-08 | 2013-01-09 | Targegen, Inc. | Benzotriazine inhibitors of kinases |
| US7652051B2 (en) | 2004-08-25 | 2010-01-26 | Targegen, Inc. | Heterocyclic compounds and methods of use |
| US20070054916A1 (en) | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
| JP2008533166A (ja) | 2005-03-16 | 2008-08-21 | ターゲジェン インコーポレーティッド | ピリミジン化合物および使用法 |
| US7906522B2 (en) | 2005-04-28 | 2011-03-15 | Kyowa Hakko Kirin Co., Ltd | 2-aminoquinazoline derivatives |
| AU2006254825A1 (en) | 2005-06-08 | 2006-12-14 | Targegen, Inc. | Methods and compositions for the treatment of ocular disorders |
| WO2007067537A1 (en) * | 2005-12-07 | 2007-06-14 | Osi Pharmaceuticals, Inc. | Pyrrolopyridine kinase inhibiting compounds |
| PE20070978A1 (es) | 2006-02-14 | 2007-11-15 | Novartis Ag | COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks) |
| BRPI0716239A2 (pt) * | 2006-08-30 | 2013-08-13 | Cellzome Ltd | derivados de triazol como inibidores de cinase |
| WO2008051757A1 (en) * | 2006-10-20 | 2008-05-02 | Irm Llc | Compositions and methods for modulating c-kit and pdgfr receptors |
| TW200829566A (en) | 2006-12-08 | 2008-07-16 | Astrazeneca Ab | Chemical compounds |
| JP2010514693A (ja) | 2006-12-22 | 2010-05-06 | ノバルティス アーゲー | Ｐｄｋ１阻害のためのキナゾリン |
| GB0719803D0 (en) * | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| WO2009155565A1 (en) * | 2008-06-20 | 2009-12-23 | Genentech, Inc. | Triazolopyridine jak inhibitor compounds and methods |
| CN102131389A (zh) * | 2008-06-20 | 2011-07-20 | 健泰科生物技术公司 | 三唑并吡啶jak抑制剂化合物和方法 |
| WO2010010184A1 (en) * | 2008-07-25 | 2010-01-28 | Galapagos Nv | [1, 2, 4] triazolo [1, 5-a] pyridines as jak inhibitors |
| WO2010010189A1 (en) * | 2008-07-25 | 2010-01-28 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| WO2010010188A1 (en) * | 2008-07-25 | 2010-01-28 | Galapagos Nv | Novel compounds useful for the treatment of degenerative and inflammatory diseases. |
| US20100041891A1 (en) * | 2008-08-12 | 2010-02-18 | Takeda Pharmaceutical Company Limited | Amide compound |
| TWI453207B (zh) * | 2008-09-08 | 2014-09-21 | Signal Pharm Llc | 胺基三唑并吡啶，其組合物及使用其之治療方法 |
-
2010
- 2010-02-09 SG SG2011057247A patent/SG173610A1/en unknown
- 2010-02-09 US US13/201,165 patent/US20120041195A1/en not_active Abandoned
- 2010-02-09 JP JP2011549537A patent/JP2012517971A/ja active Pending
- 2010-02-09 KR KR1020117018592A patent/KR20110116160A/ko not_active Withdrawn
- 2010-02-09 NZ NZ594508A patent/NZ594508A/en not_active IP Right Cessation
- 2010-02-09 BR BRPI1008850A patent/BRPI1008850A2/pt not_active IP Right Cessation
- 2010-02-09 CA CA2751517A patent/CA2751517A1/en not_active Abandoned
- 2010-02-09 EP EP10706180A patent/EP2396324A1/en not_active Withdrawn
- 2010-02-09 CN CN2010800077376A patent/CN102317288A/zh active Pending
- 2010-02-09 WO PCT/EP2010/051556 patent/WO2010092041A1/en not_active Ceased
- 2010-02-09 EA EA201101188A patent/EA201101188A1/ru unknown
- 2010-02-09 PE PE2011001470A patent/PE20120110A1/es not_active Application Discontinuation
- 2010-02-09 MX MX2011008549A patent/MX2011008549A/es not_active Application Discontinuation
- 2010-02-12 AR ARP100100400A patent/AR075411A1/es not_active Application Discontinuation
-
2011
- 2011-07-15 CR CR20110386A patent/CR20110386A/es unknown
- 2011-07-28 NI NI201100151A patent/NI201100151A/es unknown
- 2011-07-29 HN HN2011002095A patent/HN2011002095A/es unknown
- 2011-07-29 DO DO2011000248A patent/DOP2011000248A/es unknown
- 2011-08-03 TN TN2011000379A patent/TN2011000379A1/fr unknown
- 2011-08-03 IL IL214426A patent/IL214426A0/en unknown
- 2011-08-09 EC EC2011011250A patent/ECSP11011250A/es unknown
- 2011-08-11 ZA ZA2011/05896A patent/ZA201105896B/en unknown
- 2011-08-11 CO CO11102097A patent/CO6420343A2/es not_active Application Discontinuation
- 2011-08-11 CL CL2011001947A patent/CL2011001947A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012517971A5 (cg-RX-API-DMAC7.html) | ||
| JP6561167B2 (ja) | 新規な選択的ヒストン脱アセチル化酵素阻害剤としてのアザインドール誘導体およびこれを含む薬剤学的組成物 | |
| US8901150B2 (en) | 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof | |
| TWI273104B (en) | Novel fused imidazole derivative | |
| AU2014304562B2 (en) | Thieno(2,3-c)pyrans as CFTR modulators | |
| EA003697B1 (ru) | Дизамещенные бициклические гетероциклы, их получение и применение в качестве лекарственных средств | |
| JP2013504543A5 (cg-RX-API-DMAC7.html) | ||
| TW201305142A (zh) | 苯并咪唑呼吸道融合病毒抑制劑 | |
| JP2015518894A (ja) | Ｅｇｆｒ活性を調節するための化合物および組成物 | |
| JP2010521451A5 (cg-RX-API-DMAC7.html) | ||
| JP2011522866A5 (cg-RX-API-DMAC7.html) | ||
| AU2004215644A1 (en) | Pyrazolopyridine derivates | |
| JP7686741B2 (ja) | Ａｌｋ５阻害剤としてのピリダジニルアミノ誘導体 | |
| EA008596B1 (ru) | 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ | |
| EP2331541B1 (en) | Indolizine inhibitors of leukotriene production | |
| AU2013276521A1 (en) | 1,3 -dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents | |
| JP2012514020A5 (cg-RX-API-DMAC7.html) | ||
| WO2014086852A1 (en) | Phenylethylpyridine derivatives as pde4-inhibitors | |
| DK2768827T3 (en) | PROCEDURE FOR THE PREPARATION OF ISOXAZOLYL-METHOXY NICOTIC ACIDS | |
| JP6605624B2 (ja) | 新規なヘテロ環化合物、その製造方法およびこれを含む薬学的組成物 | |
| CN118871445A (zh) | 稠合的三嗪酮衍生物及其使用方法 | |
| WO2011097958A1 (zh) | 含有氨基磺酰基氮杂环丁烷基的口服碳青霉烯化合物 | |
| JP2006169138A (ja) | ピラゾロピリジンピラゾロン誘導体とその付加塩及びｐｄｅ阻害剤 | |
| EP1809632A2 (en) | Pyrazolo[4,3-d]pyrimidine derivatives useful as pde-5 inhibitors | |
| JP2015521994A5 (cg-RX-API-DMAC7.html) |